Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10
caneta tirzepatide A tirzepatida, princípio ativo de uma caneta injetável, mostrou-se eficaz e segura para crianças e adolescentes com diabetes tipo 2 Months:6 Month $29.97 pdufa date for tirzepatide
pdufa date for tirzepatide The is locked in LGMD2I/R9. The FDA has accepted our NDA
What outcome is being targeted
$29.97
Months:6 Month
Compound 28 demonstrated exceptional in vivo potency, with an IC 50 of 4.2 nM, alongside a favorable safety profile, making it a promising candidate for further preclinical research
US$ 23.13
US$ 28.71
US$ 26.32
US$ 29.05
US$ 23.66
US$ 21.88
US$ 28.52
US$ 23.48
US$ 24.95
US$ 21.25
